- 関
- metformin-rosiglitazone
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naive Type 2 Diabetes Mellitus Patients.
- Borges JL, Bilezikian JP, Jones-Leone AR, Acusta AP, Ambery PD, Nino AJ, Grosse M, Fitzpatrick LA, Cobitz AR.SourceUniversidade Catolica de Brasilia, Brasilia, DF, Brazil Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY USA Medicines Development Centre, GlaxoSmithKline, King of Prussia, PA, USA Medicines Development Centre, GlaxoSmithKline Stockley Park, UK Medicines Development Centre, GlaxoSmithKline, Upper Merion, USA.
- Diabetes, obesity & metabolism.Diabetes Obes Metab.2011 Jun 17. doi: 10.1111/j.1463-1326.2011.01461.x. [Epub ahead of print]
- Background: The purpose of this study was to evaluate if superior glycaemic control could be achieved with Avandamet(R) (rosiglitazone/metformin/AVM) compared with metformin (MET) monotherapy, and if glycaemic effects attained with AVM are durable over 18 months of treatment. Bone mineral density (
- PMID 21682834
- Links to resources such as full text articles and biological data" class="jig-ncbitoggler ui-ncbitoggler" href="#
- PMID 21595121
Related Links
- 17 Aug 2010 ... Avandamet (metformin and rosiglitazone) is used to treat type 2 diabetes. Includes Avandamet side effects, interactions and indications.
Related Pictures